TY  - JOUR
AU  - Amat-Santos, Ignacio J
AU  - Catalá, Pablo
AU  - Diez Del Hoyo, Felipe
AU  - Fernandez-Diaz, Jose A
AU  - Alonso-Briales, Juan H
AU  - Del Trigo, María
AU  - Regueiro, Ander
AU  - Juan-Salvadores, Pablo
AU  - Serra, Vicenç
AU  - Gutierrez-Ibanes, Enrique
AU  - Muñoz-García, Antonio J
AU  - Nombela-Franco, Luis
AU  - Sabate, Manel
AU  - Jimenez-Diaz, Victor A
AU  - García Del Blanco, Bruno
AU  - López, Javier
AU  - Varela-Falcón, Luis H
AU  - Sevilla, Teresa
AU  - Arnold, Roman
AU  - Revilla, Ana
AU  - San Roman, J Alberto
PY  - 2018
DO  - 10.1136/bmjopen-2017-020255
UR  - http://hdl.handle.net/10668/12130
T2  - BMJ open
AB  - Transcatheter aortic valve implantation (TAVI) as a treatment in severe aortic stenosis (AS) is an excellent alternative to conventional surgical replacement. However, long-term outcomes are not benign. Renin-angiotensin system (RAS) blockade has...
LA  - en
KW  - adult cardiology
KW  - echocardiography
KW  - heart failure
KW  - valvular heart disease
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Aortic Valve Stenosis
KW  - Heart Ventricles
KW  - Humans
KW  - Magnetic Resonance Imaging
KW  - Prospective Studies
KW  - Quality of Life
KW  - Ramipril
KW  - Renin-Angiotensin System
KW  - Research Design
KW  - Risk Factors
KW  - Transcatheter Aortic Valve Replacement
KW  - Treatment Outcome
KW  - Ventricular Dysfunction, Left
KW  - Ventricular Remodeling
TI  - Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study.
TY  - research article
VL  - 8
ER  -